Detailed answers about DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD, including incorporation, status, business activity, and accounts information.
When was DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD founded?
DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD was officially incorporated on 12 June 2025 and is registered under company number 16512993. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD?
DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD do?
DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD operates in the following sector: 86230 - Dental practice activities. This provides insight into the company's primary business activity and industry focus.
What is DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD's registered address?
The registered office address of DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD is CHESTER HOUSE LLOYD DRIVE, CHESHIRE OAKS BUSINESS PARK, ELLESMERE PORT, CHESHIRE, UNITED KINGDOM, CH65 9HQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD financially stable?
Financial accounts for DR MEETA GILL ADVANCED MEDICAL AESTHETICS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.